Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications

By afschroeder • March 4, 2026

Gupta N, Liu Y, Cai B. Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications. Immunohorizons. 2026 Feb 17;10(SI):vlag002. doi: 10.1093/immhor/vlag002. PMID: 41774843; PMCID: PMC12955849.

Tags: Atherosclerosis, cardiovascular diseases, Digestive Diseases, Efferocytosis, Macrophages, Post Doc, Publications

Targeting lipidated amino acid deficiency mitigates fibrosis via a PPARα/CCL2 axis in metabolic dysfunction-associated steatohepatitis models

Anand SK, Das S, Arias F, Richard KS, Rohilla S, Ghrayeb A, McKinney MP, Wang L, Tan L, Ding J, Kumar D, Pandey N, Lee[...]

Fibroblasts restrain gut inflammation by IGF1-dependent regulation of innate lymphocytes

Lin Q, Liu RE, Wang Q, Kang L, Chen B, Lu Y, Zhang Y, Gu Z, Zhou Y, Liu H, Xu X, Cao Z, Tang[...]

Healthy donor faecal microbiota transplantation in irritable bowel syndrome: interpreting negative findings

Liu J, Shin A. Healthy donor faecal microbiota transplantation in irritable bowel syndrome: interpreting negative findings. Lancet. 2026 Sep 24:S0140-6736(26)01815-5. doi: 10.1016/S0140-6736(26)01815-5. Epub ahead of[...]